Biological Product (Except Diagnostic) Manufacturing
NAICS 325414 · Federal Contracts & Awards
USAspending.gov records $13,183,433,554.11 in Biological Product (Except Diagnostic) Manufacturing obligations for fiscal year 2025. That yearlyTrend amount is 49.0% of NAICS 325414's $26,909,109,940.38 extract-wide total — the companion year to this slice's FY2024 325414 cell, not a replacement for it. The pair is except-diagnostic biological manufacturing plus FY2025, not a lot census and not cash already paid. The extract publishes 1,274 325414 award records industry-wide. FY figures can be incomplete for the current year.
Key figures
- USAspending records $13,183,433,554.11 in Biological Product (Except Diagnostic) Manufacturing FY2025 obligations (NAICS 325414).
- That cell is 49.0% of the industry's $26,909,109,940.38 extract-wide total.
- The FY2024 325414 cell on this slice is a different yearlyTrend row.
- 1,274 is the industry extract award-record count, not a FY2025 contract census.
What the 325414–FY2025 join is
NAICS 325414 and fiscal year 2025 meet in one yearlyTrend cell. $13,183,433,554.11 is the obligation sum tagged to that pair. It is not the FY2024 325414 cell on this slice, not pharmaceutical preparation manufacturing (325412), and not an outlay. The two 325414 years share an industry extract; they do not share a yearlyTrend row.
A second-year cell beside a first-year cell can look like a decline or a rise. This page reports $13,183,433,554.11 as given for FY2025. Ranking years as winners or losers is not the join. Correlation with product news is not causation.
FY2025 beside the 325414 longer book
49.0% of $26,909,109,940.38 landed in this cell. The FY2024 325414 pair on this slice is a different row. Adding that row into $13,183,433,554.11 would double-count. The industry hub at /industries/325414/ is the parent without a FY2025 filter. FY2025 federal spending at /fiscal-years/2025/ is the parent without a 325414 filter.
An open fiscal year can restated later. Cite $13,183,433,554.11 as obligations, not as payments already cleared on a named lot.
Full analysis: Biological Product (Except Diagnostic) Manufacturing federal obligations in FY2025 →
Questions
- How much did biological product manufacturing obligate in FY2025?
- USAspending.gov records $13,183,433,554.11 in Biological Product (Except Diagnostic) Manufacturing obligations for FY2025 under NAICS 325414. That yearlyTrend total is not an outlay and not the industry's $26,909,109,940.38 extract-wide sum. Keep Biological Product (Except Diagnostic) Manufacturing and FY2025 on the same citation as $13,183,433,554.11.
- Is $13,183,433,554.11 the same as the FY2024 325414 cell?
- No. FY2025 is 49.0% of NAICS 325414's $26,909,109,940.38 extract-wide total. The FY2024 325414 join is a separate yearlyTrend row. Do not substitute one year for the other. 1,274 is the industry extract award-record count, not a FY2025 headcount.
- Do 1,274 awards mean 1,274 FY2025 biologic contracts?
- No. 1,274 is the 325414 extract award-record count, not a FY2025-only census. The packet does not name makers. Obligations of $13,183,433,554.11 are not outlays. The pair is NAICS 325414 plus FY2025. The pair is NAICS 325414 plus FY2025.
- Does this include outlays or campaign donations?
- No. $13,183,433,554.11 is an obligation aggregate from USAspending.gov. Outlays are unpublished. FEC contribution tables do not fund these awards. USAspending.gov remains the source for NAICS 325414 in FY2025. The pair is NAICS 325414 plus FY2025.
USAspending.gov NAICS yearlyTrend by fiscal year. Obligations are not outlays. FY figures can be incomplete for the current year.
Industry ties
- Biological Product (Except Diagnostic) Manufacturing federal obligations in FY2024
- Biological Product (Except Diagnostic) Manufacturing federal obligations in FY2025
- Department of State (072) obligations in Biological Product (Except Diagnostic) Manufacturing (NAICS 325414)
- Biological Product Manufacturing (NAICS 325414) in Massachusetts 7th District (MA-07)
- Biological Product Mfg in New York 12th District (NY-12)
- Biological Product (Except Diagnostic) Manufacturing federal obligations in South Carolina
Companies in the Biological Product (Except Diagnostic) Manufacturing industry (NAICS code 325414) have received $26.91B in federal contracts, grants, and other awards since FY2024, across 1K individual awards tracked through FY2026. The largest funding agency is Department of Health and Human Services ($11.40B). Spending is concentrated in New York, Massachusetts, Maryland and 45 other states. All figures below come from USAspending.gov award records.
Total Obligations
$26.91B
Total Awards
1K
States
48
Last Updated
Apr 17, 2026
Yearly Spending Trend
$13.69B24
$13.18B25
$32.6M26
Top 50 Awards in Biological Product (Except Diagnostic) Manufacturing
Largest individual obligations in NAICS 325414.
| Award | Recipient | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|---|
CONT_AWD_W15QKN21C0012_9700_-NONE-_-NONE- DEOBLIGATION IN SUPPORT OF CLOSEOUT. | PFIZER INC New York | Department of Defense Department of the Army | — | NEW YORK, NY-12 | 2025 | $11,110,134,066 |
CONT_AWD_W58P0521C0002_9700_-NONE-_-NONE- CORONAVIRUS DISEASE 2019 (COVID-19) GLOBAL VACCINE MISSION | PFIZER INC New York | Agency for International Development Agency for International Development | — | NEW YORK, NY-12 | 2024 | $4,150,835,100 |
CONT_AWD_75A50120C00034_7505_-NONE-_-NONE- THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS), OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (… | MODERNATX, INC. Massachusetts | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | CAMBRIDGE, MA-07 | 2024 | $1,754,345,480 |
CONT_IDV_75D30119D04518_7523 2019 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $1,667,184,877 |
CONT_IDV_HHSD200201800361I_7523 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $1,516,055,054 |
CONT_IDV_75D30123D16111_7523 VACCINES FOR CHILDREN | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $841,136,855 |
CONT_AWD_75A50119C00071_7505_-NONE-_-NONE- ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. Maryland | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | GAITHERSBURG, MD-06 | 2024 | $748,857,151 |
CONT_IDV_75A50120D00002_7505 THE PURPOSE OF THIS MODIFICATION IS TO: 1) REVISE THE ATTACHMENT 0001 - INCENTIVE FEE MILESTONE SCHEDULE FOR CLINS 0002 AND 0004 PER EMAIL DATED APRIL 28, 2025. 2) FOR CLIN 0… | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2025 | $612,225,077 |
CONT_IDV_75D30121D10576_7523 VACCINES FOR CHILDREN | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $560,454,087 |
CONT_IDV_75D30122D13471_7523 VACCINES FOR CHILDREN | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $485,293,086 |
CONT_IDV_75D30120D07514_7523 VACCINES FOR CHILDREN | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $386,756,388 |
CONT_AWD_75A50124F61002_7505_75A50123D00003_7505 OTA: THE PURPOSE OF THIS MODIFICATION IS TO INCREASE THE TOTAL ESTIMATED COST AND ADD FUNDING. | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $303,999,997 |
CONT_AWD_75A50424F64001_7505_75A50123D00003_7505 OT: THE PURPOSE OF THIS MODIFICATION IS TO ADMINISTRATIVELY UPDATE ATTACHMENT 1, SECTION 7. TASK ORDER POINTS OF CONTACT | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | WASHINGTON, DC-98 | 2024 | $248,500,001 |
CONT_AWD_HHSO100200600013C_7505_-NONE-_-NONE- CLOSE CONTRACT AND DEOBLIGATE EXCESS FUNDS | DYNPORT VACCINE COMPANY LLC Maryland | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | FREDERICK, MD-06 | 2025 | $235,119,971 |
CONT_AWD_75A50124F61005_7505_75A50123D00003_7505 OT: THE PURPOSE OF THIS MODIFICATION IS TO ADMINISTRATIVELY UPDATE ATTACHMENT 1, SECTION 7. TASK ORDER POINTS OF CONTACT. | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $141,320,194 |
CONT_AWD_HHSO100201100012C_7505_-NONE-_-NONE- CLOSE CONTRACT AND DEOBLIGATE EXCESS FUNDS. THE FINAL INVOICE/VOUCHER NUMBER E001045480 IN THE AMOUNT OF $7,500,000 DATED FEBRUARY 19, 2020, WAS MADE PER THE SETTLEMENT AGREEMENT. | NOVAVAX INC Maryland | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | ROCKVILLE, MD-06 | 2025 | $121,393,966 |
CONT_IDV_HHSD200201800015I_7523 MOD TO ADD FUNDS TO PURCHASE PEDIATRIC VACCINE | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $104,899,072 |
CONT_AWD_75A50121C00009_7505_-NONE-_-NONE- THE PURPOSE OF THIS MODIFICATION IS CLOSEOUT THIS CONTRACT | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | DURHAM, NC-04 | 2024 | $102,299,549 |
CONT_IDV_75D30120D07115_7523 2020-2021 PEDIATRIC FLU SANOFI | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $102,105,604 |
CONT_IDV_HHSO100200600015I_7505 DEOBLIGATION OF EXCESS FUNDS | ROCHE LABORATORIES INC. New Jersey | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2025 | $98,153,222 |
CONT_IDV_75D30124D18412_7523 PEDIATRIC FLU VACCINES 2024-2025 | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $88,344,227 |
CONT_AWD_HHSO100201100011C_7505_-NONE-_-NONE- CLOSE CONTRACT AND DEOBLIGATE EXCESS FUNDS | VAXINNATE CORPORATION New Jersey | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | CRANBURY, NJ-12 | 2025 | $86,180,679 |
CONT_IDV_75D30122D12999_7523 PEDIATRIC FLU VACCINES 2022-2023 | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $80,283,218 |
CONT_AWD_HHSO100200600011C_7505_-NONE-_-NONE- CONTRACT CLOSEOUT DEOBLIGATE EXCESS FUNDS | GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. Pennsylvania | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | PHILADELPHIA, PA-03 | 2025 | $72,766,564 |
CONT_AWD_75A50424F64002_7505_75A50123D00003_7505 OT: THE PURPOSE OF THIS MODIFICATION IS TO ADMINISTRATIVELY UPDATE ATTACHMENT 1, SECTION 7. TASK ORDER POINTS OF CONTACT | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $61,000,000 |
CONT_AWD_75A50125C00002_7505_-NONE-_-NONE- MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SWIFTWATER, PA-08 | 2025 | $53,212,199 |
CONT_IDV_75D30120D07116_7523 ADULT FLU 2020-2021 SEQIRUS | SEQIRUS USA INC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $51,782,038 |
CONT_AWD_75A50124F61004_7505_75A50123D00003_7505 OT: THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ATTACHMENT #1, SECTION 7. TASK ORDER POINTS OF CONTACT. | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $50,679,329 |
CONT_AWD_HHSO10033005T_7505_HHSO100201600006I_7505 CLOSEOUT OF THIS EXPIRED TASK ORDER. | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SWIFTWATER, PA-08 | 2024 | $40,642,758 |
CONT_IDV_75D30124D18414_7523 PEDIATRIC FLU VACCINES 2024-2025 | SEQIRUS USA INC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $40,176,661 |
CONT_AWD_75A50124F61003_7505_75A50123D00003_7505 OT: THE PURPOSE OF THIS MODIFICATION IS TO ADMINISTRATIVELY UPDATE ATTACHMENT 1, SECTION 7 TASK ORDER POINTS OF CONTACT. | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $38,000,006 |
CONT_IDV_75D30120D07114_7523 2020-2021 ADULT FLU SANOFI | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $37,187,948 |
CONT_AWD_75A50124F61001_7505_75A50123D00003_7505 OT: THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE. | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $32,000,000 |
CONT_AWD_75A50122F61004_7505_75A50122D00004_7505 THE PURPOSE OF THIS TASK ORDER IS FOR THE ACQUISITION OF INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL. | SEQIRUS INC North Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | HOLLY SPRINGS, NC-04 | 2024 | $30,739,088 |
CONT_AWD_75A50120F33010_7505_HHSO100201600005I_7505 CLOSEOUT OF TASK ORDER. | PROTEIN SCIENCES CORP Connecticut | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | MERIDEN, CT-05 | 2024 | $29,925,884 |
CONT_IDV_75D30118D01508_7523 2018 ADULT VACCINES | GLAXOSMITHKLINE, LLC North Carolina | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $28,792,553 |
CONT_AWD_HHSD200201794412C_7523_-NONE-_-NONE- 2017 ADULT VACCINES | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | WHITEHOUSE STATION, NJ-07 | 2024 | $20,935,014 |
CONT_AWD_HHSO10033008T_7505_HHSO100201200015I_7505 CLOSEOUT OF EXPIRED TASK ORDER AND CHANGE CONTRACTING OFFICER TO DEVIN FITZMAURICE. | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SWIFTWATER, PA-08 | 2024 | $20,628,300 |
CONT_AWD_HHSO10033015T_7505_HHSO100201200014I_7505 ACQUISITION OF MCMS FOR PANDEMIC INFLUENZA PREPAREDNESS AND RESPONSE | SEQIRUS INC North Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | EMERYVILLE, CA-12 | 2025 | $20,539,764 |
CONT_IDV_HHSO100200600016I_7505 DEOBLIGATION OF EXCESS FUNDS | GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. Pennsylvania | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2025 | $19,737,801 |
CONT_AWD_75A50124F61007_7505_75A50123D00003_7505 OTA AWARD FOR BIOMAP TASK ORDER #7 FOR CBRN AVAT_MABS | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $19,620,884 |
CONT_AWD_HHSO10033024T_7505_HHSO100201200014I_7505 TO CLOSE THIS CONTRACT IN LINE WITH FAR 4.804, TO UPDATE THE CONTRACTING OFFICER TO DEVIN FITZMAURICE, AND TO DE-OBLIGATE $57,834.53 IN EXCESS FUNDS SO THE TOTAL OBLIGATION IS NOW… | SEQIRUS INC North Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | HOLLY SPRINGS, NC-04 | 2025 | $18,890,210 |
CONT_AWD_75A50124F61010_7505_75A50122D00004_7505 SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREPAREDNESS AND RESPONSE, UNDER CONTRACT 75A5012… | SEQIRUS INC North Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | HOLLY SPRINGS, NC-04 | 2024 | $18,790,750 |
CONT_IDV_75D30122D13001_7523 PEDIATRIC FLU VACCINES 2022-2023 | SEQIRUS USA INC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $18,527,344 |
CONT_IDV_75D30120D07117_7523 2020-2021 PEDIATRIC FLU SEQIRUS | SEQIRUS USA INC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $18,245,201 |
CONT_AWD_75A50119F33009_7505_HHSO100201600004I_7505 THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE OF GSK?S CONTRACT #HHSO10020160004I TASK ORDER 75A50119F33009; FROM 8/28/2019-2/28/2024 TO 8/28/2019-4/30/… | GLAXOSMITHKLINE, LLC North Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | DURHAM, NC-04 | 2024 | $18,161,554 |
CONT_AWD_75A50124F61006_7505_75A50123D00003_7505 OT: THE PURPOSE OF THIS MODIFICATION IS TO ADMINISTRATIVELY UPDATE ATTACHMENT 1, SECTION 7. TASK ORDER POINTS OF CONTACT | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $16,379,368 |
CONT_AWD_SPE2DP24F7574_9700_SPE2DP23D0004_9700 8510869772!JAPANESE ENCEPHALIT | VALNEVA USA, INC. Maryland | Department of Defense Defense Logistics Agency | — | BETHESDA, MD-08 | 2024 | $16,016,000 |
CONT_AWD_HHSO10033004T_7505_HHSO100201600004I_7505 UPDATE CONTRACTING OFFICER, CLOSEOUT CONTRACT PER FAR 4.804 | GLAXOSMITHKLINE, LLC North Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | DURHAM, NC-04 | 2024 | $15,769,590 |
CONT_AWD_75A50124F61008_7505_75A50122D00004_7505 THE PURPOSE OF THIS TASK ORDER IS TO PROCURE SERVICES FOR STORAGE AND STABILITY VACCINE BULK LOTS FROM PRIOR CONTRACTS FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTR… | SEQIRUS INC North Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | HOLLY SPRINGS, NC-04 | 2024 | $14,848,415 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Top Funding Agencies
View All→12345678910
Department of Health and Human Services$11.40B
Department of Defense$11.24B
Agency for International Development$4.15B
Department of Agriculture$66.9M
Department of Veterans Affairs$48.8M
Department of Commerce$1.3M
Department of Homeland Security$351K
Department of State$314K
Department of the Interior$232K
Environmental Protection Agency$161K
Top Recipients
View All→Spending by State
| State | Funding | Awards |
|---|---|---|
| New York | $15.26B | 48 |
| Massachusetts | $1.76B | 85 |
| Maryland | $1.19B | 154 |
| South Carolina | $663.0M | 8 |
| Pennsylvania | $290.1M | 88 |
| North Carolina | $273.9M | 53 |
| District of Columbia | $266.6M | 34 |
| New Jersey | $154.7M | 38 |
| California | $42.1M | 228 |
| Connecticut | $33.4M | 8 |
| Ohio | $23.8M | 21 |
| Georgia | $19.3M | 32 |
| Wisconsin | $11.6M | 40 |
| New Hampshire | $10.2M | 6 |
| Texas | $5.8M | 16 |
| Missouri | $4.3M | 31 |
| Washington | $3.7M | 26 |
| Colorado | $3.3M | 12 |
| Maine | $3.0M | 6 |
| Oklahoma | $3.0M | 5 |
| Louisiana | $2.5M | 6 |
| Mississippi | $2.2M | 8 |
| Vermont | $2.2M | 2 |
| Virginia | $2.1M | 24 |
| Indiana | $1.9M | 14 |
| Illinois | $794K | 24 |
| Delaware | $631K | 18 |
| Tennessee | $404K | 2 |
| Nebraska | $382K | 7 |
| Montana | $375K | 4 |
| Utah | $281K | 21 |
| Kentucky | $171K | 2 |
| Minnesota | $163K | 12 |
| New Mexico | $105K | 3 |
| Arkansas | $93K | 2 |
| Florida | $82K | 4 |
| North Dakota | $70K | 2 |
| U.S. Virgin Islands | $47K | 1 |
| Alaska | $47K | 1 |
| Iowa | $31K | 6 |
| Michigan | $30K | 5 |
| Rhode Island | $29K | 1 |
| Arizona | $23K | 2 |
| Kansas | $21K | 1 |
| Idaho | $20K | 1 |
| Alabama | $19K | 1 |
| Wyoming | $13K | 1 |
| Nevada | $0 | 1 |
Source: USAspending.gov · All Industries